A new treatment regimen helping patients with blood cancer could be effective in suppressing HIV. Researchers from the University of California, San Francisco, told The New York Times that two individuals in a trial saw HIV presence lower to undetectable levels following an experimental infusion of engineered immune cells. Detailed data on findings will soon be presented in full to the American Society of Gene and Cell Therapy in Boston. https://www.prnewswire.com/news-releases/caring-cross-announces-promising-clinical-data-with-single-dose-anti-hiv-car-t-cell-therapy-302768727.html
The HIV Survivors and Partners Network (HSPN) invites leading HIV cure research sites, academic institutions, clinical trial units, community organizations, and policy actors to join the South African HIV Cure Knowledge & Innovation Hub as Strategic Partners. Interested organizations can complete the EOI, accessible here: https://docs.google.com/forms/d/e/1FAIpQLSe8BscXXrJR8sz2oxF2LpfI5h37QrwxlcsmR-u-aO3zSixm7A/viewform?usp=sharing&ouid=105610809907167809175